Human Combination Vaccines Market by Type, Channel, and Geography - Forecast and Analysis 2023-2027

Published: Dec 2022

Pages: 168

SKU: IRTNTR44620

Snapshot

Human Combination Vaccines Market Forecast 2023- 2027

The Human Combination Vaccines Global market size is estimated to accelerate by USD 6.05 billion between 2022 and 2027 and the vaccine market size forecast is expected to increase at a CAGR of 8.13%. The emergence of has increased due to the rise of infectious diseases, the increased population of newborns, and the initiatives taken by the government to sponsor human combination vaccine programs. The treat different types of diseases such as polio, Haemophilus influenzae, and Hepatitis B vaccines. The vaccine reduced the number of injections required and boost our immunity system. GSK, Merck and Co., and Sanofi are the names of dominant market players taking over 70%-75% of the market share.

What will be the Size of the Human Combination Vaccines Market During the Forecast Period?

To learn more about this report, Download the FREE Report Sample

Market Segmentation by Type, Channel, and Geography

Type Analysis

Based on type, the market is segmented into the inactivated vaccine and live attenuated vaccine. The inactivated vaccine segment is leading the market growth among the two segments. The inactivated vaccines segment was valued at USD 8,233.69 million in 2017 and it will continue to grow during the forecast period.

Get a glance at the market contribution of various segments Request a PDF Sample

The inactivation technique provides greater coverage against various diseases. They are developed using pathogen particles that have been destroyed or killed and, therefore, cannot divide. Inactivated are safer than live vaccines because they cannot imitate a vaccinated individual, resulting in no risk of return to a virulent form capable of causing diseases. The inactivation technique allows the incorporation of viral and bacterial strains into the vaccine. The human combination inactivated can be subjected to freeze-drying and therefore are easy to store. They can be transported in large quantities across the globe. Considering the numerous advantages, the human combination inactivated will witness a high adoption rate during the forecast period, thus driving the market growth. Governments globally are continuously increasing the awareness. For instance, the United Nations Children Fund (UNICEF), a United Nations agency, and the World Health Organization (WHO) are supporting countries in their efforts to reimagine immunization by restoring services by adhering to hygiene and physical distancing recommendations and providing protective equipment to health workers. Therefore, such initiatives positively impacted the market in 2020 and are expected to continue accelerating growth during the forecast period.

Channel Analysis

Hospital pharmacies accounted for the largest share of the global market in 2022, which will continue to remain the largest segment during the forecast period. Vaccine distribution systems in hospitals are classified into in-patient and out-patient. The hospital pharmacist is competent in drug procurement, handling, pricing, and dispensing. Additionally, pharmacists serve as a liaison between patients and doctors and offer vaccine information to the public and all other healthcare professionals. Hospital pharmacists play a critical role in teaching healthcare professionals, family members, and patients about vaccines. Therefore, the hospital segment is expected to be the primary distribution channel for , which will contribute to the growth of the hospital segment of the global market during the forecast period.

Market Analyst Overview

The market plays a crucial role in immunization and disease prevention by offering a single shot that provides protection against multiple diseases. These vaccines are designed for both pediatric and adult populations, streamlining the vaccine schedule and ensuring widespread coverage. With advancements in vaccine development and manufacturing, these vaccines are becoming more effective and safe. Public health initiatives and immunization programs are driving the demand, supported by robust vaccine distribution and delivery systems. Continuous monitoring through systems like the Vaccine Adverse Events Reporting System (VAERS) ensures vaccine safety. As vaccine market trends and analysis evolve, the emphasis remains on enhancing vaccine effectiveness and optimizing the vaccine supply chain to meet global healthcare needs.

Regional Analysis

North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market analysis and report of various regions Request PDF Sample now!

North America is the largest geographical segment of the global market in 2022 and will continue to remain the largest segment of the market during the forecast period. The continuous efforts by vendors and national organizations to promote the use of will drive the growth of the market in North America during the forecast period. Additionally, the regional market is witnessing an increasing number of initiatives to generate awareness about immunization programs and increase people's access, which will also drive market growth during the forecast period.

To know more about segments download the sample reports

Key Players in Market

There is high competition in . Among several market players, the organization Pfizer stands out among the competitors due to technological innovation and its on-point marketing strategy.

Pfizer- The company provides wide range of . The company is also known for its discovery, development, manufacturing, marketing, sales, and distribution of biopharmaceutical products worldwide.

The vaccine market report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

Technavio’s report consists of a holistic analysis of the key development Analysis, development stage, pipeline analysis, FDA approval, market players, their marketing strategies, and powerful innovations to help any client gain a competitive edge.

Market Dynamic and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, market growth and trends, and challenges.

Key Market Driver

The rise in cases of infectious diseases is notably driving the market growth. Infectious diseases are a prevalent cause of sickness and death across the world. Microbes' presence and their capability to reproduce and adjust to changing populations, environments, and technologies pose a persistent threat to public health. Developing countries experience devastating impacts from infectious diseases, resulting in lower survival rates, particularly among children, and hindering economic growth and development prospects. Developed countries also face significant health and economic burdens from infectious diseases. For instance, HIV infects approximately 50,000 people annually in the US, healthcare-associated infections remain a leading cause of preventable deaths, and chronic viral infections and drug-resistant pathogens cause severe and untreatable infections. To address this challenge, the CDC is striving to reduce the incidence of these diseases by ensuring broad immunization coverage and providing access to recommended vaccines for low-income children and adults.

Significant Market Trends

Threat from bioterrorism is a major cause of concern. Bioterrorism involves the deliberate release of pathogens, including bacteria, viruses, fungi, or toxins, which can cause disease or death among living beings, including humans, animals, or plants. The emergence of new contagious diseases due to globalization has increased the potential threat of bioterrorism worldwide. Consequently, the development of new vaccines to combat bioterrorism has become essential, and developed nations are taking appropriate measures to prevent such threats. A bioterror-induced disease outbreak could lead to high demand , resulting in the need for mass vaccinations. As a result, research against potential bioterrorism agents is increasing, which is expected to boost the growth of the global market in the forecast period.

Major Market Challenge

The incompatibility of vaccine components can restrain market growth. A combination vaccine is made up of various antigens that provide immunity against different diseases. While some combinations can boost the immune response of one or more components, not all vaccine components are compatible with each other. Incompatibility can lead to vaccine instability or a suboptimal immune response. For example, combining DTaP and IPV in infants reduced the immune response to the P antigen and decreased antibody production for different antigens after two doses, and toward pertussis toxin after three doses. This resulted in a suboptimal response compared to administering these two separately. To overcome compatibility issues, extensive research with advanced biotechnological tools is necessary to modify combination vaccine immunogenicity. Such incompatibility issues may hinder the growth of the global market in the forecast period. To know more about drivers,trends, and challenges download the sample reports

Key Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Type Outlook (USD Million, 2017 - 2027)
- Inactivated vaccine
- Live attenuated vaccine

Channel Outlook (USD Million, 2017 - 2027)
- Hospitals
- Retailers
- Online

Region Outlook (USD Million, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
  - Vietnam
  - Others
- Rest of World
  - Saudi Arabia
  - South Africa
  - Brazil
  - Others

Human Combination Vaccines Market Scope
Report Coverage	Details
Page number	168
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 8.13%
Market growth 2023-2027	USD 6.05 billion
Market structure	Concentrated
YoY growth 2022-2023(%)	7.45
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 45%
Key countries	US, Canada, UK, Germany, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Abbott Laboratories, Arabio, Bharat Biotech Ltd., Biological E. Ltd., Cadila Healthcare Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Grifols SA, LG Corp., Meiji Holdings Co. Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Panacea Biotec Ltd., Pfizer Inc., PT Bio Farma, Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Walvax Biotechnology Co. Ltd.
Market dynamics	Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our market growth analysis report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Get access to Report Sample PDF !

What are the Key Data Covered in this Human Combination Vaccines Market Research and Growth Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the market growth and forecasting between 2023 and 2027
Precise estimation of the size of the market size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Vendor landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on vendor position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global human combination vaccines market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global human combination vaccines market 2017 - 2021 ($ million)

4.2 Type Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)

4.3 Channel Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Channel Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Type - Market share 2022-2027 (%)

6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type

6.3 Inactivated vaccine - Market size and forecast 2022-2027
- Exhibit 34: Chart on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Inactivated vaccine - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Inactivated vaccine - Year-over-year growth 2022-2027 (%)

6.4 Live attenuated vaccine - Market size and forecast 2022-2027
- Exhibit 38: Chart on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)

6.5 Market opportunity by Type
- Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Channel

7.1 Market segments
- Exhibit 43: Chart on Channel - Market share 2022-2027 (%)
- Exhibit 44: Data Table on Channel - Market share 2022-2027 (%)

7.2 Comparison by Channel
- Exhibit 45: Chart on Comparison by Channel
- Exhibit 46: Data Table on Comparison by Channel

7.3 Hospitals - Market size and forecast 2022-2027
- Exhibit 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibit 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

7.4 Retailers - Market size and forecast 2022-2027
- Exhibit 51: Chart on Retailers - Market size and forecast 2022-2027 ($ million)
- Exhibit 52: Data Table on Retailers - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Chart on Retailers - Year-over-year growth 2022-2027 (%)
- Exhibit 54: Data Table on Retailers - Year-over-year growth 2022-2027 (%)

7.5 Online - Market size and forecast 2022-2027
- Exhibit 55: Chart on Online - Market size and forecast 2022-2027 ($ million)
- Exhibit 56: Data Table on Online - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Chart on Online - Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Online - Year-over-year growth 2022-2027 (%)

7.6 Market opportunity by Channel
- Exhibit 59: Market opportunity by Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 61: Chart on Market share by geography 2022-2027 (%)
- Exhibit 62: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 63: Chart on Geographic comparison
- Exhibit 64: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 UK - Market size and forecast 2022-2027
- Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.9 Canada - Market size and forecast 2022-2027
- Exhibit 89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 91: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on Canada - Year-over-year growth 2022-2027 (%)

9.10 Japan - Market size and forecast 2022-2027
- Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)

9.11 Germany - Market size and forecast 2022-2027
- Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 102: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 103: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 104: Overview on factors of disruption

11.4 Industry risks
- Exhibit 105: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 106: Vendors covered

12.2 Market positioning of vendors
- Exhibit 107: Matrix on vendor position and classification

12.3 Abbott Laboratories
- Exhibit 108: Abbott Laboratories - Overview
- Exhibit 109: Abbott Laboratories - Business segments
- Exhibit 110: Abbott Laboratories - Key news
- Exhibit 111: Abbott Laboratories - Key offerings
- Exhibit 112: Abbott Laboratories - Segment focus

12.4 Bharat Biotech Ltd.
- Exhibit 113: Bharat Biotech Ltd. - Overview
- Exhibit 114: Bharat Biotech Ltd. - Product / Service
- Exhibit 115: Bharat Biotech Ltd. - Key news
- Exhibit 116: Bharat Biotech Ltd. - Key offerings

12.5 Biological E. Ltd.
- Exhibit 117: Biological E. Ltd. - Overview
- Exhibit 118: Biological E. Ltd. - Product / Service
- Exhibit 119: Biological E. Ltd. - Key offerings

12.6 Cadila Healthcare Ltd.
- Exhibit 120: Cadila Healthcare Ltd. - Overview
- Exhibit 121: Cadila Healthcare Ltd. - Business segments
- Exhibit 122: Cadila Healthcare Ltd. - Key offerings
- Exhibit 123: Cadila Healthcare Ltd. - Segment focus

12.7 CSL Ltd.
- Exhibit 124: CSL Ltd. - Overview
- Exhibit 125: CSL Ltd. - Business segments
- Exhibit 126: CSL Ltd. - Key news
- Exhibit 127: CSL Ltd. - Key offerings
- Exhibit 128: CSL Ltd. - Segment focus

12.8 Daiichi Sankyo Co. Ltd.
- Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview
- Exhibit 130: Daiichi Sankyo Co. Ltd. - Business segments
- Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news
- Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings
- Exhibit 133: Daiichi Sankyo Co. Ltd. - Segment focus

12.9 GlaxoSmithKline Plc
- Exhibit 134: GlaxoSmithKline Plc - Overview
- Exhibit 135: GlaxoSmithKline Plc - Business segments
- Exhibit 136: GlaxoSmithKline Plc - Key offerings
- Exhibit 137: GlaxoSmithKline Plc - Segment focus

12.10 Grifols SA
- Exhibit 138: Grifols SA - Overview
- Exhibit 139: Grifols SA - Business segments
- Exhibit 140: Grifols SA - Key offerings
- Exhibit 141: Grifols SA - Segment focus

12.11 LG Corp.
- Exhibit 142: LG Corp. - Overview
- Exhibit 143: LG Corp. - Business segments
- Exhibit 144: LG Corp. - Key offerings
- Exhibit 145: LG Corp. - Segment focus

12.12 Meiji Holdings Co. Ltd.
- Exhibit 146: Meiji Holdings Co. Ltd. - Overview
- Exhibit 147: Meiji Holdings Co. Ltd. - Business segments
- Exhibit 148: Meiji Holdings Co. Ltd. - Key news
- Exhibit 149: Meiji Holdings Co. Ltd. - Key offerings
- Exhibit 150: Meiji Holdings Co. Ltd. - Segment focus

12.13 Merck and Co. Inc.
- Exhibit 151: Merck and Co. Inc. - Overview
- Exhibit 152: Merck and Co. Inc. - Business segments
- Exhibit 153: Merck and Co. Inc. - Key news
- Exhibit 154: Merck and Co. Inc. - Key offerings
- Exhibit 155: Merck and Co. Inc. - Segment focus

12.14 Mitsubishi Chemical Holdings Corp.
- Exhibit 156: Mitsubishi Chemical Holdings Corp. - Overview
- Exhibit 157: Mitsubishi Chemical Holdings Corp. - Business segments
- Exhibit 158: Mitsubishi Chemical Holdings Corp. - Key offerings
- Exhibit 159: Mitsubishi Chemical Holdings Corp. - Segment focus

12.15 Pfizer Inc.
- Exhibit 160: Pfizer Inc. - Overview
- Exhibit 161: Pfizer Inc. - Product / Service
- Exhibit 162: Pfizer Inc. - Key news
- Exhibit 163: Pfizer Inc. - Key offerings

12.16 Sanofi SA
- Exhibit 164: Sanofi SA - Overview
- Exhibit 165: Sanofi SA - Business segments
- Exhibit 166: Sanofi SA - Key news
- Exhibit 167: Sanofi SA - Key offerings
- Exhibit 168: Sanofi SA - Segment focus

12.17 Serum Institute of India Pvt. Ltd.
- Exhibit 169: Serum Institute of India Pvt. Ltd. - Overview
- Exhibit 170: Serum Institute of India Pvt. Ltd. - Product / Service
- Exhibit 171: Serum Institute of India Pvt. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 172: Inclusions checklist
- Exhibit 173: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 174: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 175: Research methodology
- Exhibit 176: Validation techniques employed for market sizing
- Exhibit 177: Information sources

13.5 List of abbreviations
- Exhibit 178: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

human combination vaccines market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis